2023 NanoDay Symposium:
Continuous Manufacturing of Nanomaterials
October 11, 2023
In this symposium, FDA will provide an overview of CDER experience with approving several solid oral drug products which benefited from the continuous manufacturing technologies. We will also provide case-studies of intramural and extramural research in the areas of nanomaterials and continuous manufacturing, to further encourage the innovation and adoption of continuous manufacturing. Lastly, we will discuss ways in which industry, academia and other regulatory agencies can collaborate and engage with FDA in advancing the field of nanotechnology and continuous manufacturing.
The links below will become active on the day of the workshop.
The above rooms will open ~15 minutes before the webinar begins.
If you encounter any technical issues, visit the Technical Issues Support Page
The audio for the event will be provided through your computer speakers via Adobe Connect (there will NOT be a teleconference number to dial into). We recommend that you test your PC or mobile device prior to the event and you join the event a few minutes early to address any issues.
To test your PC, please visit:
Download Presentation Slides:
The links above will become active on the day before the event begins.
Evaluation & Certificate:
Evaluation & Certificate of Attendance
The above link will become active near the close of the first day of the event.
Recordings will be linked here as soon as they are available.
Real-time attendance is required for the certificate of attendance which can be used in support of CEs for the following professional organizations.
Certificates are only available during the two weeks post-event (until October 25, 2023).
This event has been pre-approved by:
- RAPS as eligible for a maximum of 12 credits for a two-day event (appropriate to real-time attendance) towards a participant’s RAC recertification upon full completion.
- SOCRA who accepts documentation of candidate participation in continuing education programs for re-certification if the program is applicable to clinical research regulations, operations or management, or to the candidate’s clinical research therapeutic area.
- SQA as eligible for 1 non-GCP or non-GLP unit for every 1 hour of instructional time towards a participant’s RQAP re-registration.
- ACRP for continuing education in clinical research. ACRP will provide 1 ACRP contact hour for every 45-60 minutes of qualified material.
If you have questions regarding the content of the event or other CDER-specific information, please: